Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug Interactions

Conn Med. 2016 Feb;80(2):105-11.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics
  • Dabigatran / administration & dosage*
  • Dabigatran / adverse effects
  • Dabigatran / pharmacokinetics
  • Drug Interactions
  • Humans
  • Outpatients*
  • Pyrazoles / administration & dosage*
  • Pyrazoles / adverse effects
  • Pyrazoles / pharmacokinetics
  • Pyridines / administration & dosage*
  • Pyridines / adverse effects
  • Pyridines / pharmacokinetics
  • Pyridones / administration & dosage*
  • Pyridones / adverse effects
  • Pyridones / pharmacokinetics
  • Renal Insufficiency, Chronic / drug therapy*
  • Rivaroxaban / administration & dosage*
  • Rivaroxaban / adverse effects
  • Rivaroxaban / pharmacokinetics
  • Thiazoles / administration & dosage*
  • Thiazoles / adverse effects
  • Thiazoles / pharmacokinetics
  • Venous Thromboembolism / drug therapy*

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Thiazoles
  • apixaban
  • Rivaroxaban
  • Dabigatran
  • edoxaban